The yeast two-hybrid screening technique and its use in the study of protein-protein interactions in apoptosis

Current Opinion in Immunology

Volumn 10, Issue 2, 1998, Pages 131-136

  Wallach, David ^a   Boldin, Mark P ^a   Kovalenko, Andrei V ^a   Malinin, Nikolai L ^a   Mett, Igor L ^a   Camonis, Jacques H ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN;

APOPTOSIS; CELL DEATH; GENETIC ANALYSIS; MOLECULAR CLONING; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TECHNIQUE; YEAST;

EID: 0031968027     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80240-9     Document Type: Article

References (53)

1. Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
2. Sadowski I, Ma J, Triezenberg S, Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature. 335:1988;563-564.
3. Hengartner MO, Horvitz HR. Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev. 4:1994;581-586.
4. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 22:1997;299-306.
5. Villa P, Kaufman SH, Earnshaw WC. Caspases and caspase inhibitors. Trends Biochem Sci. 22:1997;388-393.
6. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
7. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C, elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.
8. Spector MS, Desnoyers S, Hoeppner DJ, Hengartner MO. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature. 385:1997;653-656.
9. Wu D, Wallen HD, Inohara N, Nunez G. Interaction and regulation of the Caenorhabditis elegans death protease CED-3 by CED-4 and CED-9. J Biol Chem. 272:1997;21449-21454.
10. Irmler M, Hofmann K, Vaux D, Tschopp J. Direct physical interaction between the Caenorhabditis elegans 'death proteins' CED-3 and CED-4. FEBS Lett. 406:1997;189-190.
11. Chinnaiyan AM, Chaudhary D, O'Rourke K, Koonin EV, Dixit VM. Role of CED-4 in the activation of CED-3. Nature. 388:1997;728-729.
12. Van Criekinge W, Beyaert R, Van de Craen M, Vandenabeele P, Schotte P, De Valck D, Fiers W. Functional characterization of the prodomain of interleukin-1 beta-converting enzyme. J Biol Chem. 271:1996;27245-27248.
13. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
14. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, et al. FLICE, a novel FADD-homologous ICE/CED-3 like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827.
15. Duan H, Dixit VM. RAlDD is a new 'death' adapter molecule. Nature. 385:1997;86-89.
16. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor-interacting protein RIP. Cancer Res. 57:1997;615-619.
17. Farrow SN, Brown R. New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev. 6:1996;45-59.
18. Feinstein E, Wallach D, Boldin M, Varfolomeev E, Kimchi A. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci. 29:1995;342-344.
19. Sato T, Irie S, Kitada S, Reed JC. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science. 268:1995;411-415.
20. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 270:1995;7795-7798.
21. Chinnalyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512.
22. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell. 81:1995;495-504.
23. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81:1995;513-523.
24. Prasad KVS, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquit S, Schlossman SF. CD27, a member of the tumour necrosis factor receptor family, induced apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA. 94:1997;6346-6351.
25. Schievella AR, Chen JH, Graham JR, Lin LL. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem. 272:1997;12069-12075.
26. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA. 93:1996;7464-7469.
27. Vincenz C, Dixit VM. Fas-associated death domain protein interleukin-1 b-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J Biol Chem. 272:1997;6578-6583.
28. Wallach D. Apoptosis. Placing death under control. Nature. 388:1997;123-126.
29. Hofmann K, Bucher P, Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci. 22:1997;155-156.
30. Yang X, Khosravi Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 89:1997;1067-1076.
31. Wallach D. Cell death induction by TNF: a matter of self control. Trends Biochem Sci. 22:1997;107-146.
32. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
33. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IkappaB kinase. Cell. 90:1997;373-383.
34. Stankovski I, Baltimore D. NF-kB activation: The IkB kinase revealed? Cell. 91:1997;299-302.
35. Zhu L. Yeast GAL4 two-hybrid system. Methods Mol Biol. 63:1997;173-196.
36. Golemis EA, Khazak V. Alternative yeast two-hybrid systems. The interaction trap and interaction mating. Methods Mol Biol. 63:1997;197-218.
37. Bai C, Elledge SJ. Gene identification using the yeast two-hybrid system. Methods Enzymol. 283:1997;141-156.
38. Brachmann RK, Boeke JD. Tag games in yeast: the two-hybrid system and beyond. Curr Opin Biotechnol. 5:1997;561-568.
39. He W, Craparo A, Zhu Y, O'Neill TJ, Wang LM, Pierce JH, Gustafson TA. Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2. J Biol Chem. 271:1996;11641-11645.
40. Mukai H, Toshimori K, Shibata H, Takanaga H, Kitagawa M, Miyahara M, Shimakawa M, Ono Y. Interaction of PKN with alpha-actinin. J Biol Chem. 272:1997;4740-4746.
41. Chen J, Sadowski HB, Kohanski RA, Wang LH. Stat5 is a physiological substrate of the insulin receptor. Proc Natl Acad Sci USA. 94:1997;2295-2300.
42. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent APO-1(FAS/CD95)-associated proteins form a death-inducing signalling complex (DISC) with the receptor. EMBO J. 14:1995;5579-5588.
43. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
44. Shu H-B, Takeuchi M, Goeddel DV. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA. 93:1996;13973-13978.
45. Onipari AW, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor α encodes a novel type of zinc finger protein. J Biol Chem. 265:1990;14705-14712.
46. Song HY, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci USA. 93:1996;6721-6725.
47. Lee SY, Lee SY, Choi Y. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signalling complexes that inhibits TRAF2-mediated NF-kappaB activation. J Exp Med. 185:1997;1275-1285.
48. Rothe M, Xiong J, Shu H-B, Williamson K, Goddard A, Goeddel D. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA. 93:1996;8241-8246.
49. Cheng G, Baltimore D. TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-kappaB activation. Genes Dev. 10:1996;963-973.
50. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
51. Hilt W, Wolf DH. Proteasomes: destruction as a programme. Trends Biochem Sci. 21:1996;96-102.
52. Zhang J, Lautar S. A yeast three-hybrid method to clone ternary protein complex components. Anal Biochem. 242:1996;68-72.
53. Tirode F, Malaguti C, Romero F, Attar R, Camonis J, Egly JM. A conditionally expressed third partner stabilizes or prevents the formation of a transcriptional activator in a three-hybrid system. J Biol Chem. 272:1997;22995-22999.